As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: January 25, 2014
by Rebekah Marcarelli for Headlines and Global News:
Inflammation that occurs after an infection could damage the brain’s ability to form spatial memories.
Inflammation has been linked to other impairments such as Alzheimer’s disease, this new research explains why this occurs and could help lead to the development of new drugs.
The researchers worked to image the process in which inflammation impairs memory. Researchers at Brighton and Sussex Medical School performed brain scans on 20 participants who received either a “benign salty water injection or typhoid vaccination, used to induce inflammation.” The team then used positron emission tomography (PET) to observe how the inflammation affected glucose consumption in the brain. The team also used virtual reality tests to record the participants’ spatial aptitude.
“We have known for some time that severe infections can lead to long-term cognitive impairment in the elderly. Infections are also a common trigger for acute decline in function in patients with dementia and Alzheimer’s disease,” Doctor Neil Harrison, a Wellcome Trust Intermediate Clinical Fellow at BSMS who led the study, said in the news release. “This study suggests that catching a cold or the flu, which leads to inflammation in the brain, could impair our memory.”
This type of inflammation is unlikely to cause lasting effects in young and healthy individuals, but the study findings could be significant to the elderly. The team plans to see how inflammation is related to dementia in the future.
“Our findings suggest that the brain’s memory circuits are particularly sensitive to inflammation and help clarify the association between inflammation and decline in dementia,” Dr Harrison said. “If we can control levels of inflammation, we may be able to reduce the rate of decline in patients’ cognition.”
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.